维普期刊资源整合服务平台（V6.5）

110篇 您的检索式：作者名="HOSKING D"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate 显示文摘	Hosking D Lyles K Brown JP	2007	J Bone Miner Res2007，22，：	1
2	Characterizationof the P-glycoprotein over-expressing drug resistance phenotype exhibited by Chinese hamster ovary cells following their in vitro exposure to fractionated X- irradiation显示文摘	McClean S Whelan R D H Hosking L K	1993	Biochim Biophys Acta1993，1177，2：	1
3	Effects of combined prostaylandin and alendronate treatment on the histomorphometry and biomeehanical properties of bone in ovarieetomized rats显示文摘	Hosking D Chilvers C Christiansen C	1993	Bone Miner Res1993，8，7：	1
4	Ten years ex- perience with alendronate for osteoporosis in postmenopaus- al women显示文摘	Bone HG Hosking D Devogelaer JP	2004	N Engl J Meal2004，350，12：	1
5	Ten years experience with alendronate for osteoporosis in postmenopausal women显示文摘	Bone H G Hosking D Devogelaer J P	2004	N Engl J Med2004，350，12：	1
6	Ten years'experience with alendronate for osteoporosis in poslmenopausalwomen显示文摘	Bone HG Hosking D Devogelaer JP	2004	N Engl J Med2004，350，12：	1
7	Ten years' experi- ence with alendronate for osteoporosis in postmenopausal women 显示文摘	Bone HG Hosking D Devogelaer JP	2004	N Engl J Med2004，350，12：	1
8	A statistical perspective on data mining显示文摘	Hosking J R M Pednauh E P D Sudan M	1997	Future Generation Compnt- er Systems1997，13，23：	1
9	Ten years' experience with alendronate for osteoporosis in postmenopausal women显示文摘	Bone HG Hosking D Devogelaer JP	2004	N Engl J Med2004，350，：	1
10	A statistical perspective on data mining显示文摘	Hosking J R M Pednauh E P D Sudan M	1997	Future Generation Computer Sys-tema1997，13，：	1
11	Beyond the Lognormal显示文摘	Hosking J R M Bonti G Siegel D	2000	Risk2000，13，5：	1
12	The steroidreceptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differen-tiation显示文摘	Chen S L Dowhan D H Hosking B M	2000	Genes & Development2000，14，：	1
13	Baseline characteristics of tile study population in the Diabetes Arteriosclerosis Intervention Study (DAIS)显示文摘	Steiner G Stewart D Hosking JD	1999	Am J Cardiol1999，84，：	1
14	Ten years'experience with alendronate for osteoporosis in postmenopausal women显示文摘	Bone HG Hosking D Devogelaer JP T	2004	N Engl J Med2004，350，：	1
15	Baseline characteristics of the study population in the diabetes atherosclerosis intervention study(DAIS) 显示文摘	Steiner G Stewart D Hosking JD	1999	Am Cardiol1999，84，：	1
16	Prevention of bone 10SS with alendronate in postmenopausal women under 60 years of age显示文摘	Hosking D Chilvers CED Christiansen C et a1	1998	New Engl J Med1998，338，：	1
17	Ten years' experience with alendronate for osteoporosis in postmenopausal women 显示文摘	Bone HG Hosking D Devogelaer JP	2004	N Engl J Med2004，350，12：	1
18	Ten years'experience with alendronate forosteoporosis in postmenopausalwomen 显示文摘	Bone HG Hosking D Devogelaer JP	2004	N Engl J Med2004，350，：	1
19	Prevention of bone loss with alendronate in postmenopausal women under 60 years of age显示文摘	Hosking D Chilvers C E D Christiansen C	1998	N Engl J Med1998，338，：	1
20	Multiple mechanisms of resistence in a series of human testicular teratomacell lines selected for increasing resistence to etopo side显示文摘	Hosking L K W helan R D Shellard S A	1994	Int J Cancer1994，57，2：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示